Young Rodney KB 4
4 · RAPT Therapeutics, Inc. · Filed Nov 15, 2024
Insider Transaction Report
Form 4
Young Rodney KB
CHIEF FINANCIAL OFFICER
Transactions
- Disposition to Issuer
Employee Stock Option (right to buy)
2024-11-13−140,000→ 0 totalExercise: $21.73Exp: 2029-12-01→ Common Stock (140,000 underlying) - Award
Employee Stock Option (right to buy)
2024-11-13+140,000→ 140,000 totalExercise: $1.57Exp: 2029-12-01→ Common Stock (140,000 underlying) - Disposition to Issuer
Employee Stock Option (right to buy)
2024-11-13−60,000→ 0 totalExercise: $19.53Exp: 2031-01-27→ Common Stock (60,000 underlying) - Award
Employee Stock Option (right to buy)
2024-11-13+60,000→ 60,000 totalExercise: $1.57Exp: 2031-01-27→ Common Stock (60,000 underlying) - Disposition to Issuer
Employee Stock Option (right to buy)
2024-11-13−65,000→ 0 totalExercise: $19.86Exp: 2032-01-27→ Common Stock (65,000 underlying) - Award
Employee Stock Option (right to buy)
2024-11-13+68,000→ 68,000 totalExercise: $1.57Exp: 2033-01-30→ Common Stock (68,000 underlying) - Disposition to Issuer
Employee Stock Option (right to buy)
2024-11-13−90,000→ 0 totalExercise: $24.75Exp: 2034-01-30→ Common Stock (90,000 underlying) - Award
Employee Stock Option (right to buy)
2024-11-13+90,000→ 90,000 totalExercise: $1.57Exp: 2034-01-30→ Common Stock (90,000 underlying) - Award
Employee Stock Option (right to buy)
2024-11-13+65,000→ 65,000 totalExercise: $1.57Exp: 2032-01-27→ Common Stock (65,000 underlying) - Disposition to Issuer
Employee Stock Option (right to buy)
2024-11-13−68,000→ 0 totalExercise: $29.05Exp: 2033-01-30→ Common Stock (68,000 underlying)
Footnotes (9)
- [F1]The two reported transactions involved an amendment of an outstanding option, resulting in the deemed cancellation of the "old" option and the grant of a replacement option. The option was originally granted on December 2, 2019 and is fully vested.
- [F2]The two reported transactions involved an amendment of an outstanding option, resulting in the deemed cancellation of the "old" option and the grant of a replacement option. The option was originally granted on January 28, 2021.
- [F3]1/48th of the shares subject to the option vested or shall vest on each monthly anniversary of the vesting commencement date of January 1, 2021.
- [F4]The two reported transactions involved an amendment of an outstanding option, resulting in the deemed cancellation of the "old" option and the grant of a replacement option. The option was originally granted on January 28, 2022.
- [F5]1/48th of the shares subject to the option vested or shall vest on each monthly anniversary of the vesting commencement date of January 1, 2022.
- [F6]The two reported transactions involved an amendment of an outstanding option, resulting in the deemed cancellation of the "old" option and the grant of a replacement option. The option was originally granted on January 31, 2023.
- [F7]1/48th of the shares subject to the option shall vest on each monthly anniversary of the vesting commencement date of January 1, 2023.
- [F8]The two reported transactions involved an amendment of an outstanding option, resulting in the deemed cancellation of the "old" option and the grant of a replacement option. The option was originally granted on January 31, 2024.
- [F9]1/48th of the shares subject to the option shall vest on each monthly anniversary of the vesting commencement date of January 1, 2024.